Table 3. Transparency of Study Design and Reason for Discontinuation of Pediatric Studies.
| Design Characteristics | Study, No. (%) |
|---|---|
| Any information on randomization | 188 (84.7) |
| Any information on blinding | 187 (84.2) |
| Any information on comparator | 182 (82.0) |
| Any information on end point | 162 (73.0) |
| Any information on study size | 157 (70.7) |
| Any information on all 5 design characteristicsa | 148 (66.7) |
| Any reason provided for discontinuation | 13/42 (31.0) |
a
The 5 design characteristics were randomization, blinding, comparator, end point, and study size (number of participants).